CDH2 and head and neck squamous cell carcinoma: Here, we demonstrated that the novel anti-PD-L1 rFab’ was able to hamper migration, invasion and stemness of HNSCC cell lines by decreasing expression levels of p-AKT, p-ERK and mesenchymal markers such as N-cadherin and β-catenin.